The CD40 antigen, a member of the nerve growth factor/tumor necrosis factor receptor family, is expressed on all mature B lymphocytes and plays a crucial role in B cell activation, T celldependent antlgen-drlven isotype switching and germinal center formation. We have analyzed CD40 expression and function during mouse B cell development by examining B cell precursors In normal mice and In transgenic animals in which B cell development is frozen at discrete stages. These models included RAG-2"^ mice, and transgenic litter mates that express a u heavy chain and/ or the bcl-2 proto-oncogene transgene. CD40 was undetectable at the pro-B cell stage, but was expressed, although at low levels, on pre-B cells. However, pre-B cells failed to respond to CD40 triggering either by expression of CD23 or by proliferation in the presence of IL-4. Overexpresslon of bcl-2 increased the density of CD40 expression on pre-B cells: these cells respond to CD40 llgatlon by expressing CD23 and by proliferating In the presence of IL-4.
Introduction
The CD40 antigen, a member of the nerve growth factor/ tumor necrosis factor receptor family, is expressed on all mature B lymphocytes (1) . The crucial role of CD40 in B cell activation, growth and differentiation has been widely investigated (reviewed in 2). More recently, analysis of mutant mice deficient in CD40 has unambiguously shown that CD40 is required for T cell-dependent antigen-driven isotype switching and germinal center formation, but disruption of the CD40 gene does not interfere with B cell development (3, 4) .
Because CD40 plays a critical role in B cell function, it becomes important to understand how CD40 expression is regulated in B cell ontogeny. Recently, CD40 has been detected on the surface of B220 + lgM~ mouse bone marrow B cell precursors using an anti-CD40 mAb (5) . However, B220
low lgM" cells include pro-and pre-B cells since both these B cell precursors are surface lgM~. Thus the status of CD40 expression on murine B cell progenitors remains unknown. In humans there is good evidence that CD40 is expressed at the pro-B cell stage (6, 7) .
To investigate CD40 expression and function at defined stages of mouse B cell development we analyzed animals ideally suited for the study of B cell ontogeny, i.e. mice bearing mutations and/or transgenes which result in the arrest of B cell development at different stages. These included recombination activating gene (RAG)-2~^~ mice and RAG-2~'m ice complemented with a functional \i heavy chain and/or a bcl-2 transgene (8; F. Young and F. W. Alt, unpublished).
Two-and three-color flow cytometry, as well as RT-PCR analysis of bone marrow cells revealed that CD40 was undetectable at the pro-B cell stage, and was expressed, although at low levels, on pre-B cells. However, pre-B cells failed to respond to CD40 triggering either by expression of CD23 or by proliferation in the presence of IL-4.
Methods

Animals and cell preparation
RAG-?
7 " mice and RAG-? 7 " expressing the V H 186.2 heavy chain transgene (RAG-Z^'n) have been previously described (8, 9) . RAG-^ bcl-2 and RAG-2""^ dc/-2mice were obtained by crossing RAG^" and RAG-2-y "n mice with the BCL-2-lg-NL line (kind gift of S. Korsmeyer, St Louis, Ml) (10) . A single cell suspension of bone marrow was obtained from femurs and tibias of 6-to 8-week-old mice by flushing out the cells with medium.
Flow cytometric analysis
Phenotypic analysis was performed with standard techniques using phycoerythrin (PE)-, FITC-or biotin-labeled rat antimouse antibodies. Biotinylated antibodies were used in association with streptavidin-PerCP (Becton Dickinson, Mountain View, CA). Antibodies to CD45R/B220 (RA3-6B2), CD43 (S7), CD8 (53-6 7), IgM (r6-60.2 and DS-1) and CD23 (B3B4) were purchased from PharMingen (San Diego, CA). CD40 was detected on the surface of B220 + cells with a soluble CD40L-CD8 (sCD40L-CD8) fusion protein, as previously described (3) . Recently anti-mouse CD40 antibody has become commercially available (Harlan Bioproduct for Science, Indianapolis, IN) and was used to confirm the results obtained with sCD40L-CD8. Two-and three-color fluorescence was analyzed on a FACScan flow cytometer (Becton Dickinson) using the Lysys software.
RT-PCR analysis
Total RNA was extracted as described (11) from B220 + cells isolated by cell sorting on a dual laser/dye laser flow cytometer (FACStar Plus; Becton Dickinson). RNA from 5X10 5 cells were reverse-transcribed using Superscript™ RT (Gibco/BRL, Gaithersburg, MD) and oligo(dT) (Pharmacia, Piscataway, NJ) in a final volume of 50 \i\, and 6-0.75 (J.I of cDNAs were used for the PCR reactions The primers for CD40 cDNAs amplification were: 5' primer: 5'-ATGGTGTCTTTGCCTC-GGCTGTGCGCGCTATGG-3'; 3' primer 5'-GGGCTCTGT-CTTGGCTCATCTCA-3'. The primers for amplification of Pactin cDNA as a control have been previously described (11) .
Cell culture and proliferation
Cells were cultured at 10 6 /ml in RPMI 1640 (Gibco/BRL), 5% FCS Biocell, Rancho Dominguez, CA), 50 U Penicillin, 50 ng Streptomycin and 2 mM L-glutamine (Gibco/BRL) and 50 mM P-mercaptoethanol (Sigma, St Louis, MO). Proliferation was assessed by pulsing the cells with [ 3 H]thymidine (ICN, Costa Mesa, CA) after a 4 day stimulation. Supernatant of a hybridoma secreting the chimeric protein, soluble murine CD40L-CD8a (sCD40L) (kind gift of Dr P. Lane, Basel), was partially purified and used at a concentration of 12.5%, which induced optimal spleen cell proliferation in preliminary experiments. Plastic-bound anti-CD8 mAb (53-6.7) was used in selected experiments Murine recombinant IL-4 (a generous gift of Dr R. Coffman, DNAX, Palo Alto, CA) was used at 50 ng/ml.
Results
CD40 expression in normal mice
B lineage cells from spleen and bone marrow of 6-to 8-weekold RAG-2 +/ " or RAG-2 +/+ mice were examined for CD40 expression by three-color flow cytometric analysis. Figure  1(A) shows that all spleen B220 + cells expressed CD40 as assessed by binding to sCD40L (Fig. 1A, panel 1) . B220" CD40 + cells, present in the spleen, could represent dendritic cells and activated monocytes. Many of these cells were Mac-1 + (data not shown). In the bone marrow, 55-60% of B200 + cells expressed CD40 (Fig. 1A, panel 2) , all B220 h| 9 h (Fig 1 A, panel 2) , 70-75% of lgM + ( Fig 1A, panel 3 ) and all lgD + (Fig. 1A, panel 4) 
CD40 expression in mutant and/or transgenic mice
In RAG-2-deficient mice, which cannot undergo VDJ recombination (9), all bone marrow B cells are blocked at the B220 + CD43 + pro-B cell stage (9, 12) . The introduction of a functional Ig heavy chain n transgene into the RAG-2^" background (RAG-2^~n) allows pro-B cells to proceed in their development to the pre-B cell stage (|i + , light chain") (8) . We ascertained the status of CD40 expression on pro-and pre-B cells by examining the bone marrow of RAG-2-deficient and of RAG-2^"|x mice. Flow cytometric analysis of CD40 expression on bone marrow B220 + cells showed that staining for CD40 was undetectable on pro-B cells from RAG-2~^ mice ( Fig. 2 , upper left panels), whereas between 12 and 20% of B220
+ pre-B cells in RAG^'n mice expressed low levels of CD40 (Fig. 2 , upper right panels).
It has been reported that the introduction of the bcl-2 transgene in scid mice enables their B220
+ bone marrow cells to express CD40 and CD23 (13) . We examined CD40 expression on bone marrow cells from RAG-2"'" and RAG-2~/n mice expressing the bcl-2 transgene (RAG-2"^ bcl-2 and RAG-2^"n bcl-2). Introduction of the bcl-2 transgene in RAG-2^" lymphoid precursors did not allow B-lineage cells to express CD40 (Fig. 2 , lower left panels). However, overexpression of the bcl-2 transgene in RAG-2-^n B220 + cells resulted in an increase in the percentage of CD40 + cells (from -15 to 25%) as well as in 1.5-fold increase in the mean fluorescence intensity of the CD40 + cells (Fig. 2 , lower right panels). Three-color fluorescence revealed that B220 + CD43 + cells from RAG-2^~ mice and from RAG-2~'~|i mice, with or without bcl-2 transgene, were CD4CT (data not shown).
RT-PCR analysis of CD40 expression in pro-B cells
We considered the possibility that the failure to detect CD40 on pro-B cells resulted from the low sensitivity of immunofluorescence. We further assayed CD40 expression by RT-PCR on RNA obtained from B220 + bone marrow cells of RAG-2^" mice enriched (>92% B220 + ) by cell sorting. Figure 3 shows that an PCR product was amplified from as little as 7500 B220 + cells of control RAG-2 +/+ mice (>98% purity). In contrast no PCR product was amplified from up to 60,000 B220 + cells of RAG-2^" mice. A control band corresponding to p-actin was amplified from both RAG-2^" and RAG-2 +/+ cDNA. These results confirm that pro-B cells do not express detectable levels of CD40.
CD23 expression following CD40 engagement
It has been established that CD40 ligation induces CD23 expression on mature murine B cells and on human pre-B cells (7, 14, 15) . In an attempt to study whether CD40 is functional on murine pre-B cells, we tested whether CD40 engagement induces CD23 expression on pre-B cells derived from bone marrow of RAG-^'n mice. We also analyzed + lgM" were gated from a plot of B220 versus IgM and reanalyzed as histograms for the expression of CD40. CD40 was detected on the surface of B220 + cells with a sCD40L-CD8 fusion protein and developed with the PE-conjugated anti-CD8 mAb. Controls were incubated with anti-CD8 only, vertical axis represents the relative cell number and the horizontal axis the relative fluoresence with anti-CD8-PE. Less than 0.5% of cells that were stained with the developing anti-CD8 mAb alone fell within the area delineated by the horizontal bar (C) Histogram analysis of three-color fluorescence with biotinylated anti-CD40 (streptavidin-PerCP), FITC-conjugated anti-CD43 and PE-conjugated anti-B220. B22CTCD43" . Flow cytometry analysis of the expression of CD40 on B220 + cells from bone marrow of RAG-2"^ and RAG-2"' \i mice (upper panels) and from RAG-2^" bcl-2 and RAG-2^"n bcl-2 mice (lower panels) To detect CD40, cells were incubated with sCD40L followed by PEconjugated anti-mouse CD8a antibody CD8 positivity demonstrates the presence of CD40. Controls were incubated with PE-con|ugated anti-CD8 only Results are representative of four RAG-2"^ mice, four RAG-2^"n mice, three RAG-2^" bcl-2 mice and three RAG-2-^n bcl-2 mice performed in four experiments cells obtained from the bone marrow and spleen of RAG-2^" u. bcl-2 expressed CD23 when cultured for 24 h with sCD40L but not when cultured with medium alone. Introduction of the bcl-2 transgene had no effect on CD23 expression by control RAG-2^" B cells and did not reverse the inability of the RAG-2~/~ B cells to express CD23 upon CD40 stimulation.
In human B cell ontogeny CD40 is expressed at as early as at the stage of pro-B cells (6, 16) . Engagement of CD40 on B cell precursors activates a tyrosine kinase/tyrosine phosphatase pathway (6), induces CD23 expression and synergized with lymphokines to cause proliferation (7, 15) In our study we could not detect induction of CD23 expression following CD40 engagement either in pro-B cells from RAG-2~/~ mice or in pre-B cells from RAG-2~'~u. mice, despite the fact that the latter population expressed CD40. Taken together, these results suggest that CD40 signaling may be deficient in murine pre-B cells compared with murine mature B cells and human B cell precursors.
Proliferative response to CD40 ligation
Ligation of CD40 on mature B cells causes proliferation that is enhanced by IL-4 (14) We therefore examined the proliferative response of pre-B cells to CD40 ligation in the presence of IL-4 as an additional mean to assess the capacity of CD40 to transduce a proliferative signal in pre-B cells.
As expected, IL-4 and sCD40L synergized in inducing the proliferation of spleen and bone marrow cells from control RAG-2 +/~ mice (Table 1 ). In contrast, spleen and bone marrow cells from RAG-2^"u. mice as well as from RAG-2^" mice failed to proliferate in response to sCD40L + IL-4. Crosslinking of CD40 with SCD40L-CD8 captured on anfi-CD8 mAb immobilized on the bottom of plastic wells also failed to induce proliferation of pre-B cells (data not shown) The failure RAG-2 RAG-2
CD40
Ac tin -0.60 Similar results were obtained in two independent experiments and in two experiments performed with anti-CD40 mAb. Standard deviation was always <15% of the mean the notion that CD40 engagement in pre-B cells has profoundly different effects than CD40 ligation in mature B lymphocytes.
Discussion
In this paper we show that CD40 expression and function are developmentally regulated in murine B lineage lymphocytes. We first analyzed by immunofluorescence bone marrow cells from normal mice to determine the stage at which CD40 is expressed in B cell development (Fig 1A) . Pro-B cells defined by the B220 + CD43 + phenotype expressed no detectable CD40 on their surface. These results were confirmed by analyzing bone marrow cells from RAG-2~/~ mice whose bone marrow B220 + cells are blocked at the pro-B cell stage (Fig.  1B) . Our inability to detect CD40 on murine pre-B cells was not simply due to lack of sensitivity of the immunofluorescence assay. Indeed RT-PCR analysis of B220 + cells from the bone marrow of RAG-2^" mice revealed no evidence of CD40 mRNA in these cells (Fig. 2) . The lack of CD40 expression on murine pro-B cells differs from the reported expression of CD40 on human pro-B cell populations (6, 7) .
CD40 was expressed on a fraction of B220 + lgM~ cells from normal bone marrow (Fig. 1B) albeit at a lower density than on mature B cells. B220 + lgM~ cells include predominantly pre-B cells as well as pro-B cells. Since B220 + CD43 + pro-B cells did not express CD40 (Fig. 1C) , these results suggested that CD40 is expressed by pre-B cells. These results were confirmed by the observation that CD40 was expressed by a fraction of B220 + cells from the bone marrow of RAG-2^~n mice (Fig. 1B) in which B cell development is arrested at the pre-B cell stage. The observation that CD40 expression is first detected in pre-B cells suggests that expression of heavy chain protein could be a prerequisite for CD40 expression in murine B cells Despite the expression of CD40 on pre-B cells CD40 ligation on these cells with SCD40L failed to induce CD23 expression and failed to induce proliferation in the presence of IL-4 ( Fig.  3 and Table 1 ). This failure was not due to the inability of pre-B cells to express CD23, since CD23 was inducible on pre-B cells by PMA. Furthermore, although pre-B cells are responsive to IL-4, as evidenced by the increased expression of IL-2Ra, no proliferative response was observed in the presence of IL-4 and sCD40L These results suggest that CD40 may not be coupled to signal transducing pathways that result in pre-B cell proliferation. Alternatively, the density of CD40 on the surface of pre-B cells may be too low for CD40 ligation to reach the threshold of activation necessary to transduce a signal. We also cannot exclude the engagement of CD40 in pre-B cells leads to cell death. In this respect engagement of tumor necrosis factor receptors and the Fas receptor, which belong to the same family of molecules as CD40, can lead to either cell death or proliferation depending on the cell type and on the stage of cellular activation (17) (18) (19) .
bcl-2 is expressed at high levels at the pro-B and mature B cell stages and is down-regulated as the pre-B cell stage (11) which is characterized by extensive cell death (20) . Overexpression of bcl-2 increased the density of CD40 expression on the pre-B cells and what is more important, it allowed these cells to express CD23 upon CD40 triggering and to proliferate upon the addition of sCD40L and IL-4. The higher proliferative response of the spleen cells from RAG-2~*~\i bcl-2 mice compared to the bone marrow cells was not due to higher percentage of B220 + cells in the spleen (data not shown). It suggests that pre-B cells in RAG-Z^n bcl-2 mice that respond to anti-CD40 + IL-4 may have a selective advantage in populating the peripheral lymphoid organs and/ or that factors exerted on these pre-B cells in the periphery enhance their proliferative response.
The mechanisms by which overexpression of bcl-2 enabled pre-B cells to respond to CD40 ligation need to be investigated. Overexpression of bcl-2 in FtAG-2^"n mice may have allowed the selective survival of a small subpopulation of pre-B cells which was intrinsically competent to respond to CD40 stimulation. This subpopulation would be very poorly represented in pre-B cells from RAG-2^"n mice. Alternatively, by increasing the expression of CD40 on pre-B cells, overexpression of bcl-2 may have allowed cross-linking of CD40 to reach the threshold required for effective signaling. Finally expression of bcl-2 may have corrected a qualitative defect in CD40 signaling in pre-B cells. We cannot exclude the possibility that bcl-2 blocked a putative CD40-mediated apoptosis in pre-B cells.
The lack of CD40 expression and/or function in murine B cell precursors shown in this paper suggests that CD40 may not play a critical role early in B cell development This is consistent with the observation that apparently normal numbers of B cells accumulate in the periphery of mice with homozygous disruption of the CD40 gene (3, 4) 
